Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators.
Heikki V HuikuriAri PelliTuomas V KenttäTim FriedeRik WillemsLeonard BergauMarek MalikBert VandenberkMarc A VosGeorg SchmidtBela MerkelyAndrzej LubinskiMartin SvetlosakFrieder BraunschweigMarkus HardenMarkus ZabelHeikki V HuikuriChristian Sticherlingnull nullPublished in: Diabetes care (2019)
All-cause mortality is higher in patients with diabetes than in patients without diabetes with primary prophylactic ICDs. Subsequently, patients with diabetes have a lower incidence of appropriate ICD shocks, indicating that the excess mortality might not be caused primarily by ventricular tachyarrhythmias. These findings suggest a limitation of the potential of prophylactic ICD therapy to improve survival in patients with diabetes with impaired left ventricular function.
Keyphrases
- left ventricular
- type diabetes
- end stage renal disease
- cardiovascular disease
- risk factors
- heart failure
- cardiovascular events
- chronic kidney disease
- ejection fraction
- newly diagnosed
- cardiac resynchronization therapy
- glycemic control
- peritoneal dialysis
- prognostic factors
- mitral valve
- risk assessment
- bone marrow
- left atrial
- atrial fibrillation
- replacement therapy
- catheter ablation